Overview
Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery
Status:
Completed
Completed
Trial end date:
2018-08-01
2018-08-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functionsPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Benha UniversityTreatments:
Mosapride
Criteria
Inclusion Criteria:- all women undergoing elective cesarean section
Exclusion Criteria:
- prior abdominal surgery, abdominal adhesion, chronic constipation, allergy to
mosapride